Latest Shareholder Approvals News

Baumart Holdings has completed a modest capital raise through a rights issue, securing $182,303 before costs, with plans to issue additional shortfall shares to bolster its funding position.

Pacific Edge Limited has launched a NZ$20 million capital raise to bolster its cash reserves amid the loss of Medicare coverage for its bladder cancer diagnostic tests, aiming to accelerate US market adoption and support new product development.

Pacific Edge Limited reported a resilient FY25 performance despite losing Medicare coverage for its Cxbladder tests in the US, announcing a $20 million equity raise to support commercialization and growth.

CZR Resources has won overwhelming shareholder approval to sell its Robe Mesa Iron Ore Project to a Rio Tinto-Mitsui joint venture for approximately A$75 million, setting the stage for a significant portfolio reshuffle.

Rare Foods Australia Limited has requested an immediate suspension of its shares on the ASX, paving the way for its voluntary removal from the exchange next month. This move follows shareholder approval earlier this year.

InVert Graphite has successfully completed a $3.5 million public share offer, meeting a key condition for its ASX reinstatement and advancing its strategic acquisitions.

Locate Technologies has secured $1.45 million through a share placement and established a $2 million At-the-Market facility to boost financial flexibility, while unveiling a strategic plan to hold Bitcoin as part of its treasury management.

TruScreen Limited has obtained a waiver from NZ RegCo allowing it to allot oversubscribed shares up to 10 business days after its capital raising offer closes, subject to shareholder approval. This move aims to streamline the company’s NZ$3 million placement and share purchase plan.

Prospech Limited has successfully raised $1 million through a 50 million share placement, aiming to accelerate exploration efforts in Finland and Slovakia, with a particular focus on expanding the Korsnäs resource.

TruScreen Group Limited has announced a capital raising initiative involving Placement and Share Purchase Plan (SPP) Options, aiming to secure approximately NZ$3 million to fund strategic growth and working capital needs. The offer, subject to shareholder approval, includes up to 80.9 million Placement Options and 55.5 million SPP Options exercisable at A$0.02.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.